Oxyntomodulin vs BI 456906

Head-to-head comparison of Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) and BI 456906 (BI 456906, glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyOxyntomodulinBI 456906
CategoryWeight ManagementWeight Management
Full NameEndogenous glucagon-like peptide 1 and glucagon co-agonist peptideBI 456906, glucagon-like peptide-1/glucagon receptor dual agonist
Molecular Weight~4,200 DaN/A
Half-Life12-15 minutesApproximately 1 week
Amino Acids37N/A
Typical DoseResearch doses vary; commonly 100-300 mcg in small human studiesTrial-dependent; weekly SC dosing
RouteSubcutaneous/IVSubcutaneous
Purity≥98%≥98%
Studies Count8010
Research StatusClinicalClinical

Oxyntomodulin Benefits

  • reduces appetite
  • increases satiety
  • supports weight loss
  • improves postprandial metabolic signaling

BI 456906 Benefits

  • weight reduction
  • improved glucose control
  • lower liver-fat burden
  • enhanced satiety

Oxyntomodulin Dosing

Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring

BI 456906 Dosing

once-weekly subcutaneous injection|stepwise titration|ongoing maintenance phase

Oxyntomodulin Side Effects

  • nausea
  • GI discomfort
  • decreased appetite beyond target

BI 456906 Side Effects

  • nausea
  • abdominal discomfort
  • diarrhea

Research Overview

Oxyntomodulin

Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.

BI 456906

Preclinical and early clinical research support meaningful metabolic effects with a tolerable safety profile. It remains investigational and is not commercially available.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Oxyntomodulin stacks with:

calorie-deficitresistance-training

BI 456906 stacks with:

metforminbupropion
GLP-1glucagon-coagonistendogenous-peptideappetite-regulationglp1glucagondual-agonistweight-lossmetabolic-disease